Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To study the safety and efficacy of Autologous Umbilical Cord Blood Mononuclear Cells transfusion on clinical outcome in preterm infants
This is a Phase 1 clinical trial that constitutes two time points cohorts with 100 participants per cohort who will receive intravenous doses of Autologous Umbilical Cord Blood Mononuclear Cells --25 million cells/kg, 48 hours after birth. And the placebo will be 0.9% sodium chloride.The investigator will proceed the groups during the same period.
Demographic Data and Baseline Characteristics of the Studied Groups were collected:
Assessment of clinical condition in the course by measurement of arterial blood pressure, heart and respiratory rates and skin temperature was recorded continuously
Autologous cord blood mononuclear cells doses is 25 million cells/kg ,the infusion speed is 4ml/kg/h, 8-12h,and with same volume of 0.9% sodium chloride as placebo.
The following are monitored at 3、7、14、21 days after birth:
Long-term follow up: in 1m, 3m, 6m,1y: neurodevelopment [Bayley Scales of Infant], asthma, anemia and physique growth.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo1 | Placebo Comparator | 0.9% sodium chloride infusion 48 hours after birth ,the infusion speed is 4ml/kg/h, 8-12h, |
|
| CBMNC | Experimental | Autologous Umbilical Cord Blood Mononuclear Cells Therapy 48 hours after birth ,dose is 25 million cells/kg ,the infusion speed is 4ml/kg/h, 8-12h, |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Autologous Umbilical Cord Blood Mononuclear Cells Therapy | Other | Autologous Umbilical Cord Blood Mononuclear Cells Therapy in preterm for safety and effect evaluation |
|
| Measure | Description | Time Frame |
|---|---|---|
| number of patients who died | mortality rate | up tp 21 days after birth |
| Measure | Description | Time Frame |
|---|---|---|
| number of patients with neurodevelopmental disorder assessed by Bayley Score | Long term follow up: in 1 month, 3 months, 6 months, and 1 year: neuro-development | up to 1 month, 3 months, 6 months and 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| zhuxiao Ren, MD | Contact | +8613538984634 | +86 | renzhx1990@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Jie Yang, Phd | Guangdong Women and Children Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jie Yang | Recruiting | Guangzhou | Guangdong | 511442 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23673863 | Result | Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013 Jul 25;122(4):491-8. doi: 10.1182/blood-2013-02-453175. Epub 2013 May 14. | |
| 32300579 | Derived | Ren Z, Fang X, Zhang Q, Mai YG, Tang XY, Wang QQ, Lai CH, Mo WH, Dai YH, Meng Q, Wu J, Ao ZZ, Jiang HQ, Yang Y, Qu LH, Deng CB, Wei W, Li Y, Wang QI, Yang J. Use of Autologous Cord Blood Mononuclear Cells Infusion for the Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: A Study Protocol for a Placebo-Controlled Randomized Multicenter Trial [NCT03053076]. Front Pediatr. 2020 Apr 2;8:136. doi: 10.3389/fped.2020.00136. eCollection 2020. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 27, 2020 | |
| Unrelease | May 29, 2020 | |
| Release | Jun 18, 2020 |
Not provided
Not provided
Not provided
Not provided
Not provided
| 0.9% Sodium Chloride | Drug | 0.9% Sodium Chloride in control group |
|
| Reset | Jul 10, 2020 |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 27, 2020 | May 29, 2020 | |||
| Jun 18, 2020 | Jul 10, 2020 |
| ID | Term |
|---|---|
| D066087 | Perinatal Death |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003643 | Death |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D012965 | Sodium Chloride |
| ID | Term |
|---|---|
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
| D017670 | Sodium Compounds |
Not provided
Not provided